An eye implant developed by USC — the first FDA approved implant of its kind — is helping people with a rare type of vision loss regain some sight and is paving the way for more "bionic eyes" to treat other forms of blindness in the future.
Dubbed the Argus II, it was designed to treat retinitis pigmentosa, a genetic disorder that slowly robs a person of sight by destroying photoreceptors in the eye, reports KPCC's Sanden Totten.
Read the full story: USC 'bionic eye' implant offers some blind patients new sight